Robotic surgery and cancer drugs - agenda of the Transparency Council meeting

Agenda:

1. Preparation of a position on the qualification of the health care benefit:
   "Robotic thoracic surgery (lung and other thoracic cancers)"
   as a guaranteed benefit.
   
2. Preparation of a position paper on the evaluation of the drug Kisqali (ribociclibum) under the drug program:
   B.9.FM. "Treatment of patients with breast cancer (ICD-10: C50)".
   
3. Preparation of a position paper on the examination of the appropriateness of issuing approvals for reimbursement of the medicinal product:
   Raxone(idebenonum) for the indication:
   Leber hereditary optic nerve neuropathy in pediatric patients - continuation of treatment in which the patient benefited.
   
4. Preparation of an opinion on the draft health policy program of the local government unit:
   "Medical rehabilitation of residents of the Municipality of Malczyce".

Source: AOTMiT